Current evidence and future research needs for FeNO measurement in respiratory diseases

Respiratory Medicine

Volumn 108, Issue 6, 2014, Pages 830-841

  Bjermer, Leif ^a   Alving, Kjell ^b   Diamant, Zuzana ^a,c   Magnussen, Helgo ^d   Pavord, Ian ^e   Piacentini, Giorgio ^f,g   Price, David ^h   Roche, Nicolas ⁱ   Sastre, Joaquin ^j   Thomas, Mike ^k   Usmani, Omar ^l  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

^d Pulmonary Research Institute   (Germany)

^e GLENFIELD HOSPITAL   (United Kingdom)

^f UNIVERSITY OF VERONA   (Italy)

^g Transfusion Service   (Italy)

^h UNIVERSITY OF ABERDEEN   (United Kingdom)

ⁱ UNIVERSITÉ PARIS DESCARTES   (France)

^j INSTITUTO DE SALUD CARLOS III   (Spain)

^k UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^l ROYAL BROMPTON HOSPITAL   (United Kingdom)

more..

Author keywords

Breath test; Diagnosis; Eosinophil; Health economy; Therapy monitoring

Indexed keywords

CORTICOSTEROID; NITRIC OXIDE; BIOLOGICAL MARKER;

ASTHMA; CLINICAL PRACTICE; DISEASE EXACERBATION; EXPIRED AIR; FRACTION OF EXHALED NITRIC OXIDE; HUMAN; LUNG FUNCTION; MEASUREMENT; MEDICATION COMPLIANCE; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PREDICTIVE VALUE; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT INFLAMMATION; REVIEW; RISK FACTOR; TH2 CELL; TREATMENT PLANNING; TREATMENT RESPONSE; ADOLESCENT; ADULT; AGE; AGED; BREATH ANALYSIS; CHILD; FORECASTING; LUNG FUNCTION TEST; MIDDLE AGED; PATHOPHYSIOLOGY; PROCEDURES; RESPIRATORY TRACT DISEASES; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; BIOMARKERS; BREATH TESTS; CHILD; FORECASTING; HUMANS; MEDICATION ADHERENCE; MIDDLE AGED; NITRIC OXIDE; RESPIRATORY FUNCTION TESTS; RESPIRATORY TRACT DISEASES; YOUNG ADULT;

EID: 84902244482     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2014.02.005     Document Type: Review

References (99)

1. D. Shaw, R. Green, M. Berry, S. Mellor, B. Hargadon, and M. Shelley et al. A cross-sectional study of patterns of airway dysfunction, symptoms and morbidity in primary care asthma Prim Care Respir J 21 2012 283 287
2. E.S. Starren, N.J. Roberts, M. Tahir, L. O'Byrne, R. Haffenden, and I.S. Patel et al. A centralised respiratory diagnostic service for primary care: a 4-year audit Prim Care Respir J 21 2012 180 186
3. A. Jatakanon, S. Lim, S.A. Kharitonov, K.F. Chung, and P.J. Barnes Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma Thorax 53 1998 91 95
4. T.A. Mahr, J. Malka, and J.D. Spahn Inflammometry in pediatric asthma: a review of fractional exhaled nitric oxide in clinical practice Allergy Asthma Proc 34 2013 210 219
5. D. Ludviksdottir, Z. Diamant, K. Alving, L. Bjermer, and A. Malinovschi Clinical aspects of using exhaled NO in asthma diagnosis and management Clin Respir J 6 2012 193 207
6. K. Alving, and A. Malinovschi Basic aspects of exhaled nitric oxide Eur Respir Monogr 49 2010 1 31
7. C.M. Hart Nitric oxide in adult lung disease Chest 115 1999 1407 1417
8. R. Korhonen, A. Lahti, H. Kankaanranta, and E. Moilanen Nitric oxide production and signaling in inflammation Curr Drug Targets Inflamm Allergy 4 2005 471 479
9. C. Lane, D. Knight, S. Burgess, P. Franklin, F. Horak, and J. Legg et al. Epithelial inducible nitric oxide synthase activity is the major determinant of nitric oxide concentration in exhaled breath Thorax 59 2004 757 760
10. R.A. Dweik, R.L. Sorkness, S. Wenzel, J. Hammel, D. Curran-Everett, and S.A. Comhair et al. Use of exhaled nitric oxide measurement to identify a reactive, at-risk phenotype among patients with asthma Am J Respir Crit Care Med 181 2010 1033 1041
11. L.A. Perez-de-Llano, F. Carballada, O. Castro Anon, M. Pizarro, R. Golpe, and A. Baloira et al. Exhaled nitric oxide predicts control in patients with difficult-to-treat asthma Eur Respir J 35 2010 1221 1227
12. A.D. Smith, J.O. Cowan, K.P. Brassett, S. Filsell, C. McLachlan, and G. Monti-Sheehan et al. Exhaled nitric oxide: a predictor of steroid response Am J Respir Crit Care Med 172 2005 453 459
13. G.S. Berlyne, K. Parameswaran, D. Kamada, A. Efthimiadis, and F.E. Hargreave A comparison of exhaled nitric oxide and induced sputum as markers of airway inflammation J Allergy Clin Immunol 106 2000 638 644
14. A.C. Olin, A. Rosengren, D.S. Thelle, L. Lissner, B. Bake, and K. Toren Height, age, and atopy are associated with fraction of exhaled nitric oxide in a large adult general population sample Chest 130 2006 1319 1325
15. A.F. Gelb, S.C. George, F. Camacho, C. Fraser, C. Flynn Taylor, and S. Shakkottai Increased nitric oxide concentrations in the small airway of older normal subjects Chest 139 2011 368 375
16. M. Olivieri, G. Talamini, M. Corradi, L. Perbellini, A. Mutti, and C. Tantucci et al. Reference values for exhaled nitric oxide (reveno) study Respir Res 7 2006 94
17. L.P. Malmberg, T. Petays, T. Haahtela, T. Laatikainen, P. Jousilahti, and E. Vartiainen et al. Exhaled nitric oxide in healthy nonatopic school-age children: determinants and height-adjusted reference values Pediatr Pulmonol 41 2006 635 642
18. A. Malinovschi, J.A. Fonseca, T. Jacinto, K. Alving, and C. Janson Exhaled nitric oxide levels and blood eosinophil counts independently associate with wheeze and asthma events in National Health and Nutrition Examination Survey subjects J Allergy Clin Immunol 132 4 2013 821 827
19. A. Sverrild, A. Malinovschi, C. Porsbjerg, V. Backer, and K. Alving Predicting airway hyperreactivity to mannitol using exhaled nitric oxide in an unselected sample of adolescents and young adults Respir Med 107 2013 150 152
20. K.C. See, and D.C. Christiani Normal values and thresholds for the clinical interpretation of exhaled nitric oxide levels in the U.S. General Population: results from NHANES 2007-2010 Chest 143 1 2013 107 116
21. M.G. Persson, O. Zetterstrom, V. Agrenius, E. Ihre, and L.E. Gustafsson Single-breath nitric oxide measurements in asthmatic patients and smokers Lancet 343 1994 146 147
22. B. Bake, K Toren, and A.C. Olin Modeling of exhaled nitric oxide in relation to smoking history - a population based study Eur Respir J 40 Suppl. 56 2012 4303 [Conference abstract, ERS]
23. A. Malinovschi, V. Backer, H. Harving, and C. Porsbjerg The value of exhaled nitric oxide to identify asthma in smoking patients with asthma-like symptoms Respir Med 106 2012 794 801
24. W. Zetterquist, C. Pedroletti, J.O. Lundberg, and K. Alving Salivary contribution to exhaled nitric oxide Eur Respir J 13 1999 327 333
25. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005 Am J Respir Crit Care Med 171 2005 912 930
26. C. Gabriele, M.W. Pijnenburg, F. Monti, W. Hop, M.E. Bakker, and J.C. de Jongste The effect of spirometry and exercise on exhaled nitric oxide in asthmatic children Pediatr Allergy Immunol 16 2005 243 247
27. A.K. Tee, and K.P. Hui Effect of spirometric maneuver, nasal clip, and submaximal inspiratory effort on measurement of exhaled nitric oxide levels in asthmatic patients Chest 127 2005 131 134
28. L. Prieto, L. Ruiz-Jimenez, and J. Marin The effect of spirometry on bronchial and alveolar nitric oxide in subjects with asthma J Asthma 50 2013 623 628
29. J.E. Brussee, H.A. Smit, M. Kerkhof, L.P. Koopman, A.H. Wijga, and D.S. Postma et al. Exhaled nitric oxide in 4-year-old children: relationship with asthma and atopy Eur Respir J 25 2005 455 461
30. K.M. Romero, C.L. Robinson, L.M. Baumann, R.H. Gilman, R.G. Hamilton, and N.N. Hansel et al. Role of exhaled nitric oxide as a predictor of atopy Respir Res 14 2013 48
31. M. Scott, A. Raza, W. Karmaus, F. Mitchell, J. Grundy, and R.J. Kurukulaaratchy et al. Influence of atopy and asthma on exhaled nitric oxide in an unselected birth cohort study Thorax 65 2010 258 262
32. T.C. Yao, L.S. Ou, W.I. Lee, K.W. Yeh, L.C. Chen, and J.L. Huang Exhaled nitric oxide discriminates children with and without allergic sensitization in a population-based study Clin Exp Allergy 41 2011 556 564
33. J.D. Boot, S. de Haas, S. Tarasevych, C. Roy, L. Wang, and D. Amin et al. Effect of an NK1/NK2 receptor antagonist on airway responses and inflammation to allergen in asthma Am J Respir Crit Care Med 175 2007 450 457
34. S.P. Sanders, D. Proud, S. Permutt, E.S. Siekierski, R. Yachechko, and M.C. Liu Role of nasal nitric oxide in the resolution of experimental rhinovirus infection J Allergy Clin Immunol 113 2004 697 702
35. H.W. De Gouw, S.J. Marshall-Partridge, H. Van Der Veen, J.G. Van Den Aardweg, P.S. Hiemstra, and P.J. Sterk Role of nitric oxide in the airway response to exercise in healthy and asthmatic subjects J Appl Physiol 90 2001 586 592
36. F.A. Mendes, F.M. Almeida, A. Cukier, R. Stelmach, W. Jacob-Filho, and M.A. Martins et al. Effects of aerobic training on airway inflammation in asthmatic patients Med Sci Sports Exerc 43 2011 197 203
37. A. Moreira, L. Delgado, T. Haahtela, J. Fonseca, P. Moreira, and C. Lopes et al. Physical training does not increase allergic inflammation in asthmatic children Eur Respir J 32 6 2008 1570 1575
38. V. Luks, A. Burkett, L. Turner, and S. Pakhale Effect of physical training on airway inflammation in animal models of asthma: a systematic review BMC Pulm Med 13 2013 24
39. J.D. Boot, L. de Ridder, M.L. de Kam, C. Calderon, M.A. Mascelli, and Z. Diamant Comparison of exhaled nitric oxide measurements between NIOX MINO electrochemical and ecomedics chemiluminescence analyzer Respir Med 102 2008 1667 1671
40. British Thoracic Society, and Scottish Intercollegiate Guidelines Network British guideline on the management of asthma. A national clinical guideline 2012 http://www.sign.ac.uk/guidelines/fulltext/101/contents.html
41. Global strategy for asthma management and prevention 2012 www.ginasthma.org
42. S.E. Wenzel Asthma: defining of the persistent adult phenotypes Lancet 368 2006 804 813
43. D.N. Payne, I.M. Adcock, N.M. Wilson, T. Oates, M. Scallan, and A. Bush Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone Am J Respir Crit Care Med 164 2001 1376 1381
44. T.J. Warke, P.S. Fitch, V. Brown, R. Taylor, J.D. Lyons, and M. Ennis et al. Exhaled nitric oxide correlates with airway eosinophils in childhood asthma Thorax 57 2002 383 387
45. Z. Zietkowski, A. Bodzenta-Lukaszyk, M.M. Tomasiak, R. Skiepko, and M. Szmitkowski Comparison of exhaled nitric oxide measurement with conventional tests in steroid-naive asthma patients J Investig Allergol Clin Immunol 16 2006 239 246
46. A.D. Smith, J.O. Cowan, S. Filsell, C. McLachlan, G. Monti-Sheehan, and P. Jackson et al. Diagnosing asthma: comparisons between exhaled nitric oxide measurements and conventional tests Am J Respir Crit Care Med 169 2004 473 478
47. C. Lemiere, P. Ernst, R. Olivenstein, Y. Yamauchi, K. Govindaraju, and M.S. Ludwig et al. Airway inflammation assessed by invasive and noninvasive means in severe asthma: eosinophilic and noneosinophilic phenotypes J Allergy Clin Immunol 118 2006 1033 1039
48. P. Haldar, C.E. Brightling, B. Hargadon, S. Gupta, W. Monteiro, and A. Sousa et al. Mepolizumab and exacerbations of refractory eosinophilic asthma N Engl J Med 360 2009 973 984
49. J. Corren, R.F. Lemanske, N.A. Hanania, P.E. Korenblat, M.V. Parsey, and J.R. Arron et al. Lebrikizumab treatment in adults with asthma N Engl J Med 365 2011 1088 1098
50. P.Y. Hahn, T.Y. Morgenthaler, and K.G. Lim Use of exhaled nitric oxide in predicting response to inhaled corticosteroids for chronic cough Mayo Clin Proc 82 2007 1350 1355
51. S.J. Szefler, B.R. Phillips, F.D. Martinez, V.M. Chinchilli, R.F. Lemanske, and R.C. Strunk et al. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma J Allergy Clin Immunol 115 2005 233 242
52. Z. Zietkowski, I. Kucharewicz, and A. Bodzenta-Lukaszyk The influence of inhaled corticosteroids on exhaled nitric oxide in stable chronic obstructive pulmonary disease Respir Med 99 2005 816 824
53. B. Antus Role of exhaled nitric oxide in predicting steroid response in chronic obstructive pulmonary disease Orv Hetil 151 2010 2083 2088
54. P.E. Silkoff, P. McClean, M. Spino, L. Erlich, A.S. Slutsky, and N. Zamel Dose-response relationship and reproducibility of the fall in exhaled nitric oxide after inhaled beclomethasone dipropionate therapy in asthma patients Chest 119 2001 1322 1328
55. K. Gorska, R. Krenke, P. Korczynski, J. Kosciuch, J. Domagala-Kulawik, and R. Chazan Eosinophilic airway inflammation in chronic obstructive pulmonary disease and asthma J Physiol Pharmacol 59 Suppl. 6 2008 261 270
56. K.A. Scott, and A.J. Wardlaw Eosinophilic airway disorders Semin Respir Crit Care Med 27 2006 128 133
57. J.F. Dummer, M.J. Epton, J.O. Cowan, J.M. Cook, R. Condliffe, and C.E. Landhuis et al. Predicting corticosteroid response in chronic obstructive pulmonary disease using exhaled nitric oxide Am J Respir Crit Care Med 180 2009 846 852
58. E.M. Klaassen, K.D. van Kant, Q. Jobsis, S.T. Hovig, C.P. van Schayck, and G.T. Rijkers et al. Symptoms, but not a biomarker response to inhaled corticosteroids, predict asthma in preschool children with recurrent wheeze Mediat Inflamm 2012 2012 162571
59. L. Prieto, A. Ferrer, S. Ponce, J. Palop, and J. Marin Exhaled nitric oxide measurement is not useful for predicting the response to inhaled corticosteroids in subjects with chronic cough Chest 136 2009 816 822
60. I. Amirav, and A. Zacharasiewicz Non-invasive monitoring of inflammation in asthma using exhaled nitric oxide Isr Med Assoc J 10 2008 146 148
61. National Heart, Lung and Blood Institute National asthma education and prevention program, expert panel report 3: guidelines for the diagnosis and management of asthma 2007 https://www.nhlbi.nih.gov/guidelines/asthma/
62. Mvd Berge, NHTt Hacken, H.A.M. Kerstjens, and D.S. Postma Management of asthma with ICS and LABAs: different treatment strategies Clin Med Insights Ther 1 2009 77 93
63. A.D. Smith, J.O. Cowan, K.P. Brassett, G.P. Herbison, and D.R. Taylor Use of exhaled nitric oxide measurements to guide treatment in chronic asthma N Engl J Med 352 2005 2163 2173
64. H. Powell, V.E. Murphy, D.R. Taylor, M.J. Hensley, K. McCaffery, and W. Giles et al. Management of asthma in pregnancy guided by measurement of fraction of exhaled nitric oxide: a double-blind, randomised controlled trial Lancet 378 2011 983 990
65. J. Syk, A. Malinovschi, G. Johansson, A.-L. Undén, A. Andreasson, M. Lekander, and K. Alving Anti-inflammatory treatment of atopic asthma guided by exhaled nitric oxide: a randomized, controlled trial J Allergy Clin Immunol Pract 1 2013 639 648
66. J.C. de Jongste, S. Carraro, W.C. Hop, and E. Baraldi Daily telemonitoring of exhaled nitric oxide and symptoms in the treatment of childhood asthma Am J Respir Crit Care Med 179 2009 93 97
67. S.J. Szefler, H. Mitchell, C.A. Sorkness, P.J. Gergen, G.T. O'Connor, and W.J. Morgan et al. Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial Lancet 372 2008 1065 1072
68. D.E. Shaw, M.A. Berry, M. Thomas, R.H. Green, C.E. Brightling, and A.J. Wardlaw et al. The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial Am J Respir Crit Care Med 176 2007 231 237
69. W.J. Calhoun, B.T. Ameredes, T.S. King, N. Icitovic, E.R. Bleecker, and M. Castro et al. Comparison of physician-, biomarker-, and symptom-based strategies for adjustment of inhaled corticosteroid therapy in adults with asthma: the BASALT randomized controlled trial JAMA 308 2012 987 997
70. H.L. Petsky, C.J. Cates, A. Li, J.A. Kynaston, C. Turner, and A.B. Chang Tailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children and adults Cochrane Database Syst Rev 2009 CD006340
71. J.F. Donohue, and N. Jain Exhaled nitric oxide to predict corticosteroid responsiveness and reduce asthma exacerbation rates Respir Med 107 2013 943 952
72. H.K. Reddel, D.R. Taylor, E.D. Bateman, L.P. Boulet, H.A. Boushey, and W.W. Busse et al. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice Am J Respir Crit Care Med 180 2009 59 99
73. A. Moeller, C. Diefenbacher, A. Lehmann, M. Rochat, J. Brooks-Wildhaber, and G.L. Hall et al. Exhaled nitric oxide distinguishes between subgroups of preschool children with respiratory symptoms J Allergy Clin Immunol 121 2008 705 709
74. R.S. Zeiger, S.J. Szefler, B.R. Phillips, M. Schatz, F.D. Martinez, and V.M. Chinchilli et al. Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma J Allergy Clin Immunol 117 2006 45 52
75. R.A. Dweik, P.B. Boggs, S.C. Erzurum, C.G. Irvin, M.W. Leigh, and J.O. Lundberg et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications Am J Respir Crit Care Med 184 2011 602 615
76. G.L. Piacentini, D.G. Peroni, A. Bodini, E. Bonafiglia, E. Rigotti, and E. Baraldi et al. Childhood Asthma Control Test and airway inflammation evaluation in asthmatic children Allergy 64 2009 1753 1757
77. M.L. Paro-Heitor, M.H. Bussamra, B.M. Saraiva-Romanholo, M.A. Martins, T.S. Okay, and J.C. Rodrigues Exhaled nitric oxide for monitoring childhood asthma inflammation compared to sputum analysis, serum interleukins and pulmonary function Pediatr Pulmonol 43 2008 134 141
78. M.W. Pijnenburg, W. Hofhuis, W.C. Hop, and J.C. De Jongste Exhaled nitric oxide predicts asthma relapse in children with clinical asthma remission Thorax 60 2005 215 218
79. A. Zacharasiewicz, N. Wilson, C. Lex, E.M. Erin, A.M. Li, and T. Hansel et al. Clinical use of noninvasive measurements of airway inflammation in steroid reduction in children Am J Respir Crit Care Med 171 2005 1077 1082
80. M.W. Pijnenburg, E.M. Bakker, W.C. Hop, and J.C. De Jongste Titrating steroids on exhaled nitric oxide in children with asthma: a randomized controlled trial Am J Respir Crit Care Med 172 2005 831 836
81. G. Stern, J. de Jongste, R. van der Valk, E. Baraldi, S. Carraro, and C. Thamrin et al. Fluctuation phenotyping based on daily fraction of exhaled nitric oxide values in asthmatic children J Allergy Clin Immunol 128 2011 293 300
82. P.G. Gibson Using fractional exhaled nitric oxide to guide asthma therapy: design and methodological issues for ASthma TReatment ALgorithm studies Clin Exp Allergy 39 2009 478 490
83. E.J. Peirsman, T.J. Carvelli, P.Y. Hage, L.S. Hanssens, L. Pattyn, and M.M. Raes et al. Exhaled nitric oxide in childhood allergic asthma management a randomised controlled trial Pediatr Pulmonol 2013 [n/a-n/a]
84. H. Nolte, I. Pavord, V. Backer, S. Spector, T. Shekar, and D. Gates et al. Dose-dependent anti-inflammatory effect of inhaled mometasone furoate/formoterol in subjects with asthma Respir Med 107 2013 656 664
85. J. Beck-Ripp, M. Griese, S. Arenz, C. Koring, B. Pasqualoni, and P. Bufler Changes of exhaled nitric oxide during steroid treatment of childhood asthma Eur Respir J 19 2002 1015 1019
86. E.S. Koster, J.A. Raaijmakers, S.J. Vijverberg, and A.H. Maitland-van der Zee Inhaled corticosteroid adherence in paediatric patients: the PACMAN cohort study Pharmacoepidemiol Drug Saf 20 2011 1064 1072
87. D.M. McNicholl, M. Stevenson, L.P. McGarvey, and L.G. Heaney The utility of fractional exhaled nitric oxide suppression in the identification of nonadherence in difficult asthma Am J Respir Crit Care Med 186 2012 1102 1108
88. P. Montuschi, C. Mondino, P. Koch, G. Ciabattoni, P.J. Barnes, and G. Baviera Effects of montelukast treatment and withdrawal on fractional exhaled nitric oxide and lung function in children with asthma Chest 132 2007 1876 1881
89. A. Sandrini, I.M. Ferreira, C. Gutierrez, J.R. Jardim, N. Zamel, and K.R. Chapman Effect of montelukast on exhaled nitric oxide and nonvolatile markers of inflammation in mild asthma Chest 124 2003 1334 1340
90. N.A. Hanania, S. Wenzel, K. Rosen, H.J. Hsieh, S. Mosesova, and D.F. Choy et al. Exploring the effects of omalizumab in allergic asthma Am J Respir Crit Care Med 187 2013 804 811
91. R.S. Zeiger, M. Schatz, F. Zhang, W.W. Crawford, M.S. Kaplan, and R.M. Roth et al. Elevated exhaled nitric oxide is a clinical indicator of future uncontrolled asthma in asthmatic patients on inhaled corticosteroids J Allergy Clin Immunol 128 2011 412 414
92. A.F. Gelb, C. Flynn Taylor, C.M. Shinar, C. Gutierrez, and N. Zamel Role of spirometry and exhaled nitric oxide to predict exacerbations in treated asthmatics Chest 129 2006 1492 1499
93. S.L. Jones, J. Kittelson, J.O. Cowan, E.M. Flannery, R.J. Hancox, and C.R. McLachlan et al. The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control Am J Respir Crit Care Med 164 2001 738 743
94. S. Sonnappa, C.M. Bastardo, S. Saglani, A. Bush, and P. Aurora Relationship between past airway pathology and current lung function in preschool wheezers Eur Respir J 38 2011 1431 1436
95. S. Sonnappa, C.M. Bastardo, A. Bush, and P. Aurora Exhaled nitric oxide measurements from different analyzers Chest 138 2010 1275 1277
96. I.H. van Veen, A. Ten Brinke, P.J. Sterk, J.K. Sont, S.A. Gauw, and K.F. Rabe et al. Exhaled nitric oxide predicts lung function decline in difficult-to-treat asthma Eur Respir J 32 2008 344 349
97. A. Malinovschi Both intermediate and high exhaled nitric oxide lecels predict improvement in asthma control after new-onset of inhaled corticosteroids EAACI-WAO Congress 2013
98. D. Price, J. Berg, and P. Lindgren An economic evaluation of NIOX MINO airway inflammation monitor in the United Kingdom Allergy 64 2009 431 438
99. J. Berg, and P. Lindgren Economic evaluation of FE(NO) measurement in diagnosis and 1-year management of asthma in Germany Respir Med 102 2008 219 231